b'L sciencesorganizationsfromColorado is just a ife startups to well-established multi-billion dollar companiescontinue to choose Colorado because it delivers the completegreat spot to do drug package: world-class talent, ready-to-scale infrastructure and room for expansion, adiscovery science.vibrant scientific community, and incentives for businesses to establish and expand here. Add to these assets Colorados draw as aSTEVEN ANDREWS, Ph.D., SENIOR VICE PRESIDENT, great place to live and work, and you have allADVANCED MOLECULE DESIGN, LILLY SMALL MOLECULE DISCOVERYthe components for a thriving life sciences ecosystem. and to have business discussions with small,approval by the FDA in 2019 for mantle cell Colorado Hub for Health Impact, the nationalemerging companies. lymphoma and certain patients with CLL/SLL economic development campaign elevatingLilly, one of the worlds largest medicineand is now being studied in five Phase 3 trials. Colorado as a leading location for health inno- manufacturers with a 145-year history, moreOne of the secrets to that success is the vation, illustrates these key reasons why com- than 100 patented medications, and twoaccess to a strong talent pool of scientists panies, talent, and investors choose ColoradoNobel prizes for medicine, acquired Loxoto make strong teams. The work hard/play for relocation and expansion. Here, we highlightOncology in 2019 and opened a new researchhard culture in Colorado is one of its biggest four companies that chose Colorado becauseand development facility in Louisville in 2022.assets to recruiting and retaining top scien-of our rise as a life sciences leader.The acquisition significantly expanded Lillystific talent. That kind of tenacious spirit to Global powerhouses, such as Lilly Oncologyoncology pipeline with a focus on researchdo tough science actually goes hand-in-hand and CordenPharma, are making large invest- and development of new cancer medicines.with conquering outdoor challenges, which is ments in the state to drive their productsThe new, 115,000-square-foot Lilly Oncologyendemic to the Colorado area, says Andrews.and the science behind them forward. Early- facility in Louisville employs 165 scientists inThe future of health innovation is strong at stage companies, including Entirely Well andthe lab along with a significant number ofthe Louisville Lilly Oncology site. We have Numiera Therapeutics, are finding the supportcontractors, with an estimated 200 peoplenumerous programs and they address a lot of they need to move to the next level throughonsite at any given time.different cancer types. Lilly has a strong desire investments, affordable lab space, and com- Science is really a team sport, says Andrews,to help patients and making new medicines is mitted talent.who acknowledges having the team in thea big part of that, says Andrews. Lilly Oncology: Globalsame location fosters high levels of collabo- Entirely Well: Womens Health ration, making the research and development Manufacturer Develops Cancermore efficient. This means patients benefitFounder Calls Colorado Medicines in Coloradofrom new, more effective drugs developed ona Rocket for Growth The opportunity to innovate alongside prom- shorter timelines. One of the visions of theWhen she was a student, Reilly Williams was ising startups in a drug discovery hotspotsite was building a community of scientists inso driven to be at the forefront of innovation made the choice to expand in Colorado easya great location, says Andrews.and entrepreneurship, she applied to the for Lilly Oncology in Louisville. Colorado isLilly recently reported a significant successmost competitive internship in the world at just a great spot to do drug discovery science.with positive topline results announced fromTeslaover 60 timesultimately winning it There is a culture of innovation in BoulderPhase 3 of Jaypirca, a non-covalent Brutonsbecause of her tenacity. and Boulder County in particular, says Stevetyrosine kinase (BTK) inhibitor for differentThe Tesla internship put Williams on the fast Andrews, Senior Vice President of Advancedtypes of blood cancers, like chronic lymphocytictrack, connecting her with R.J. Scaringe, the Molecular Design at Lilly Small Moleculeleukemia or small lymphocytic lymphoma. TheCEO of Rivian Automotive, who offered the Discovery. There are a lot of biotechs here,Louisville site contributed to the developmentaspiring entrepreneur her dream job when so it makes a great community to recruit talentof the medicine. Jaypirca received acceleratedshe graduated. As the first female Material, 2025-2026 BIOSCIENCE COLORADO 37'